---
title: "Orphenadrine - Parkinsonism - 3"
sidebar: mydoc_sidebar
permalink: db01173-mesh-d020734-3.html
toc: false 
---


Path ID: `DB01173_MESH_D020734_3`
{% include image.html url="images/db01173-mesh-d020734-3.png" file="db01173-mesh-d020734-3.png" alt="db01173-mesh-d020734-3" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009966 | Orphenadrine | Drug |
| REACT:R-HSA-390648 | Muscarinic acetylcholine receptors | Pathway |
| GO:0007271 | Synaptic transmission, cholinergic | BiologicalProcess |
| MESH:D020734 | Parkinsonism | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Orphenadrine | NEGATIVELY REGULATES | Muscarinic Acetylcholine Receptors |
| Muscarinic Acetylcholine Receptors | POSITIVELY REGULATES | Synaptic Transmission, Cholinergic |
| Synaptic Transmission, Cholinergic | POSITIVELY CORRELATED WITH | Parkinsonism |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01173](https://go.drugbank.com/drugs/DB01173)
  - [https://en.wikipedia.org/wiki/Parkinsonism](https://en.wikipedia.org/wiki/Parkinsonism)
